Skip to main content

Table 1 Pathway analysis of differential metabolites from global metabolomics

From: Integration of global metabolomics and lipidomics approaches reveals the molecular mechanisms and the potential biomarkers for postoperative recurrence in early-stage cholangiocarcinoma

Pathways

Hits

Raw p

Holm adjust

FDR

Impact

Pyruvate metabolism

1

0.047

0.901

0.083

0.207

Alanine, aspartate and glutamate metabolism

4

0.029

0.668

0.083

0.197

Citrate cycle (TCA cycle)

3

0.016

0.389

0.083

0.169

Arginine and proline metabolism

5

0.043

0.901

0.083

0.156

Glycolysis/gluconeogenesis

1

0.047

0.901

0.083

0.100

Glycine, serine, and threonine metabolism

4

0.044

0.901

0.083

0.093

Glyoxylate and dicarboxylate metabolism

4

0.022

0.524

0.083

0.032

Propanoate metabolism

1

0.032

0.711

0.083

0

Cysteine and methionine metabolism

1

0.047

0.901

0.083

0

Tyrosine metabolism

1

0.047

0.901

0.083

0

Butanoate metabolism

2

0.050

0.901

0.083

0

  1. Hits matched metabolites in the pathway, raw p original p value calculated from enrichment analysis, Holm adjust adjust p value from Bonferroni method, FDR false discovery rate, Impact pathway impact calculated from topology analysis